HR 1672
17 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Gave to its sponsors8 of 30
William SR. Harris$19KPatricia Jarman Mauldin$18KStacy Schusterman$17KDaniel Simon$16KJoel A. Rubinstein$15KSylvia C. Sabel$15KBarry Boothe$15KBrenda S. Baker$14KSponsors51 cosponsors more
Donald DavisCongress · North Carolina · DHR 1672
Maintaining Investments in New Innovation Act
Congress · In committee
Every link on this map
The same connections as a table, with the reason each one is here.
| William SR. Harris | Gave to its sponsors | William SR. Harris gave $19K to a sponsor of HR 1672. A gift is not a position on the bill. | $19K |
| Patricia Jarman Mauldin | Gave to its sponsors | Patricia Jarman Mauldin gave $18K to a sponsor of HR 1672. A gift is not a position on the bill. | $18K |
| Stacy Schusterman | Gave to its sponsors | Stacy Schusterman gave $17K to a sponsor of HR 1672. A gift is not a position on the bill. | $17K |
| Daniel Simon | Gave to its sponsors | Daniel Simon gave $16K to a sponsor of HR 1672. A gift is not a position on the bill. | $16K |
| Joel A. Rubinstein | Gave to its sponsors | Joel A. Rubinstein gave $15K to a sponsor of HR 1672. A gift is not a position on the bill. | $15K |
| Sylvia C. Sabel | Gave to its sponsors | Sylvia C. Sabel gave $15K to a sponsor of HR 1672. A gift is not a position on the bill. | $15K |
| Barry Boothe | Gave to its sponsors | Barry Boothe gave $15K to a sponsor of HR 1672. A gift is not a position on the bill. | $15K |
| Brenda S. Baker | Gave to its sponsors | Brenda S. Baker gave $14K to a sponsor of HR 1672. A gift is not a position on the bill. | $14K |
| Donald Davis | Sponsors | Donald Davis sponsored HR 1672. | None |
| Novartis | Lobbied on it | Novartis named HR 1672 in 38 lobbying reports. | 38 reports |
| Alnylam Pharmaceuticals, Inc. | Lobbied on it | Alnylam Pharmaceuticals, Inc. named HR 1672 in 21 lobbying reports. | 21 reports |
| Ionis Pharmaceuticals, Inc. | Lobbied on it | Ionis Pharmaceuticals, Inc. named HR 1672 in 14 lobbying reports. | 14 reports |
| Todd Strategy Group | Lobbied on it | Todd Strategy Group named HR 1672 in 14 lobbying reports. | 14 reports |
| Amgen, Inc. | Lobbied on it | Amgen, Inc. named HR 1672 in 10 lobbying reports. | 10 reports |
| Biotechnology Innovation Organization | Lobbied on it | Biotechnology Innovation Organization named HR 1672 in 10 lobbying reports. | 10 reports |
| Healthcare Institute of New Jersey | Lobbied on it | Healthcare Institute of New Jersey named HR 1672 in 10 lobbying reports. | 10 reports |
| Public Citizen | Lobbied on it | Public Citizen named HR 1672 in 10 lobbying reports. | 10 reports |